ABCA4 and retinal disorder: These results provide a framework for developing new therapeutic strategies for treating retinal disorders and potentially other conditions caused by the pathologic build-up of ceramides, such as the ones observed in the Abca4−/− mouse model of Stargardt early-onset macular degeneration (30) or rd10 mouse model of RP (15).